Open
SectorHealthcare
1.32 -11.41
24h
Min
1.32
Max
1.5
Income | 3.6M -34M |
|---|---|
Sales | 278K 1.9M |
Profit margin | -1,786.576 |
Employees | 181 |
EBITDA | 979K -37M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +185.16% upside |
Next Earnings | 10 lis 2025 |
|---|
Market Cap | 71M 179M |
|---|---|
Previous open | 12.73 |
Previous close | 1.32 |
By Acuity
31%
69%
88 / 373 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 4.42 USD 185.16%
High 7 USD
Low 2 USD
Based on 8 Wall Street analysts offering 12 month price targets forFate Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$